{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:12:40Z","timestamp":1793729560071,"version":"4.6.1"},"reference-count":21,"publisher":"FapUNIFESP (SciELO)","issue":"2b","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2005,6]]},"abstract":"<jats:p>Topiramate infrequently induces anion gap metabolic acidosis through carbonic anhydrase inhibition on the distal tubule of the nephron - a type 2 renal tubular acidosis. We report on a 40 years old woman previously healthy that developed significant asymptomatic metabolic acidosis during topiramate therapy at a dosage of 100mg\/day for three months. Stopping medication was followed by normalization of the acid-base status within five weeks. This infrequent side effect appears unpredictable and should be given careful attention.<\/jats:p>","DOI":"10.1590\/s0004-282x2005000300032","type":"journal-article","created":{"date-parts":[[2006,1,9]],"date-time":"2006-01-09T13:40:39Z","timestamp":1136814039000},"page":"532-534","source":"Crossref","is-referenced-by-count":14,"title":["Topiramate and severe metabolic acidosis: case report"],"prefix":"10.1590","volume":"63","author":[{"given":"Jayme E.","family":"Burmeister","sequence":"first","affiliation":[{"name":"Hospital Luterano; Universidade Luterana do Brasil, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael R.","family":"Pereira","sequence":"additional","affiliation":[{"name":"Hospital Luterano; Universidade Luterana do Brasil, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa M.","family":"Hartke","sequence":"additional","affiliation":[{"name":"Hospital Luterano; Universidade Luterana do Brasil, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Kreuz","sequence":"additional","affiliation":[{"name":"Hospital Luterano; Universidade Luterana do Brasil, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1684\/j.1950-6945.2004.tb00053.x","article-title":"Antiepileptic drugs: indications other than epilepsy","volume":"6","author":"Spina E","year":"2004","journal-title":"Epileptic Disord"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/J354v16n04_03","article-title":"Newer anticonvulsant drugs in neuropathic pain and bipolar disorder","volume":"16","author":"Chandramouli J","year":"2002","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jama.291.8.965","article-title":"Topiramate for migraine prevention: a randomized controlled trial","volume":"25","author":"Brandes JL","year":"2004","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneur.61.4.490","article-title":"Topiramate in migraine prevention: results of a large controlled trial","volume":"61","author":"Silberstein SD","year":"2004","journal-title":"Arch Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9942","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1590\/S0004-282X2004000100016","article-title":"Topiramato no tratamento preventivo da migr\u00e2nea: experi\u00eancia em um centro terci\u00e1rio","volume":"62","author":"Krymchantowski AV","year":"2004","journal-title":"Arq Neuropsiquiatr","ISSN":"https:\/\/id.crossref.org\/issn\/0004-282X","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1365-2044.2004.03884.x","article-title":"Topiramate induced metabolic acidosis","volume":"59","author":"Ozer Y","year":"2004","journal-title":"Anaesthesia","ISSN":"https:\/\/id.crossref.org\/issn\/0003-2409","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF01997718","article-title":"Efficacy and safety of topiramate in refractory epilepsy: a long-term prospective trial","volume":"17","author":"Tartara A","year":"1996","journal-title":"Ital J Neurol Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0392-0461","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/ebeh.2002.0339","article-title":"Topiramate overdose: clinical and laboratory features","volume":"3","author":"Fakhoury T","year":"2002","journal-title":"Epilepsy Behav"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1046\/j.1528-1157.2002.00602.x","article-title":"Concomitant treatment with topiramate and ketogenic diet in pediatric epilepsy","volume":"43","author":"Takeoka M","year":"2002","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.1528-1157.2002.37201.x","article-title":"Topiramate and metabolic acidosis in infants and toddlers","volume":"43","author":"Philippi H","year":"2002","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/0883073800015001S05","article-title":"Safety and tolerability of topiramate in children","volume":"15","author":"Levisohn PM","year":"2000","journal-title":"J Child Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0883-0738","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1590\/S0004-282X2000000600007","article-title":"Predisposition to metabolic acidosis induced by topiramate","volume":"58","author":"Montenegro MA","year":"2000","journal-title":"Arq Neuropsiquiatr","ISSN":"https:\/\/id.crossref.org\/issn\/0004-282X","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1592\/phco.20.1.105.34662","article-title":"Acute mental status changes and hyperchloremic metabolic acidosis with long-term topiramate therapy","volume":"20","author":"Stowe CD","year":"2000","journal-title":"Pharmacotherapy","ISSN":"https:\/\/id.crossref.org\/issn\/0277-0008","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1528-1157.1999.tb00781.x","article-title":"Topiramate and metabolic acidosis","volume":"40","author":"Wilner A","year":"1999","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1017\/S0012162201001268","article-title":"Topiramate-induced metabolic acidosis: report of two cases","volume":"43","author":"Ko CH","year":"2001","journal-title":"Dev Med Child Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1622","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.amjmed.2003.08.021","article-title":"Topiramate-induced renal tubular acidosis","volume":"116","author":"Izzedine H","year":"2004","journal-title":"Am J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9343","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1528-1157.2001.04500.x","article-title":"Topiramate and metabolic acidosis in pediatric epilepsy","volume":"42","author":"Takeoka M","year":"2001","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref18","series-title":"Up to date","volume-title":"Etiology and diagnosis of type 1 and type 2 renal tubular acidosis","author":"Rose BD","year":"2004"},{"key":"ref19","series-title":"Up to date","volume-title":"Approach to the adult with metabolic acidosis","author":"Post TW","year":"2004"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1528-1157.2000.tb02169.x","article-title":"Topiramate as an inhibitor of carbonic anhydrase isoenzymes","volume":"41","author":"Dodgson SJ","year":"2000","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref21","first-page":"127","article-title":"Metabolic and endocrine effects of metabolic acidosis in humans","volume":"131","author":"Wiederkehr M","year":"2001","journal-title":"Swiss Med Wkly"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v63n2b\/a32v632b.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T19:41:58Z","timestamp":1736192518000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2005000300032&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":21,"journal-issue":{"issue":"2b","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0004-282X2005000300032"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x2005000300032","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}